Stockreport

Investors in Regeneron Pharmaceuticals (NASDAQ:REGN) have seen stellar returns of 220% over the past five years [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
PDF But on a lighter note, a good company can see its share price rise well over 100%. Long term Regeneron Pharmaceuticals, Inc. NASDAQ:REGN ) shareholders would be well awa [Read more]